Attached files

file filename
10-Q - Revolutions Medical CORPv223010_10q.htm
EX-31.1 - Revolutions Medical CORPv223010_ex31-1.htm
EX-32.2 - Revolutions Medical CORPv223010_ex32-2.htm
EX-31.2 - Revolutions Medical CORPv223010_ex31-2.htm

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002
 
In connection with this Quarterly Report of Revolutions Medical Corporation (the “Company”), on Form 10-Q for the quarter ended March 31, 2011, as filed with the U.S. Securities and Exchange Commission on the date hereof, I, Rondald L. Wheet, Principal Executive Officer of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

 
(1)
Such Quarterly Report on Form 10-Q for the quarter ended March 31, 2011, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 
(2)
The information contained in such Quarterly Report on Form 10-Q for the quarter ended March 31, 2011, fairly presents, in all material respects, the financial condition and results of operations of the Company.
  
Date: May 17, 2011  
By:
/s/ Rondald L. Wheet
 
   
Rondald L. Wheet
 
   
Principal Executive Officer
Revolutions Medical Corporation